

Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.669, 2013-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Newborn hearing screening potentially cost saving in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 392, 2002-01 ,pp. :


No cost saving with risperidone
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 247, 2000-01 ,pp. :


Atorvastatin cost saving in hypercholesterolaemia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 407, 2003-01 ,pp. :


Atorvastatin cost saving in hypercholesterolaemia
Inpharma, Vol. 1, Iss. 1382, 2003-01 ,pp. :


Adding cetuximab to RT: ahead for cost effectiveness in Taiwan
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 640, 2011-01 ,pp. :